About the Journal

Synergy in Biological and Pharmaceutical Sciences (Synergy BPS) is a peer-reviewed, open access, multidisciplinary journal committed to advancing research at the intersection of drug discovery and biopharmaceutical innovation.
The journal publishes high-impact original studies and critical reviews that connect medicinal chemistry, pharmacognosy, biotechnology, pharmacology, and phytochemistry, with a focus on translating discoveries into next-generation therapeutics from bench to bedside.

Scope

Natural Products & Drug Discovery

• Isolation, structural characterisation, and biological evaluation of plant-, marine-, and microbe-derived compounds
• Ethnopharmacology and artificial intelligence-driven compound screening
• Mechanistic studies of biological and biochemical processes underlying disease

Medicinal Chemistry & Synthetic Biology

• Structure–activity relationship (SAR) analyses and lead compound optimization
• Semi-synthesis and synthetic biology approaches to bioactive molecule production

Biotechnology & Biopharmaceutics

• Application of CRISPR, metabolic engineering, and recombinant systems for therapeutic development
• Nanocarriers and targeted drug delivery systems

Pharmacology & Therapeutics

• Mechanistic pharmacology of novel agents (e.g., kinase inhibitors, GPCR ligands)
• Preclinical and translational research linking laboratory findings to clinical potential

Phytochemistry & Traditional Medicine

• Standardisation and chemical profiling of herbal medicines
• Investigations into the synergy of multi-component traditional remedies

Journal Salient Features

• Interdisciplinary Vision: Integrates natural and synthetic bioactive compounds with modern pharmaceutical development
• Therapeutic Relevance: Showcasing studies with translational and clinical potential
• Commitment to Open Science: Promotes data sharing, including genomic and metabolomic resources

Target Audience

• Medicinal chemists, pharmacologists, and biotechnologists
• Researchers in natural products, phytotherapy, and pharmacognosy
• Pharmaceutical industry professionals involved in drug R&D

 Article Types

• Original Research (Experimental or Computational)
• Review Articles (Systematic and Mini Reviews)
• Spotlights (Emerging technologies such as AI in drug discovery)
• Short Communications (Brief reports of significant advances)
• Commentaries (Ethical, policy, and strategic insights in biopharmaceutical sciences)

Publication Frequency

Synergy operates on an annual volume model, publishing articles online continuously upon acceptance. At the end of each calendar year, these articles are assembled into that year’s volume. Synergy BPS will commence publication starting with Volume 2025.

Article Preparation

Please see the Author Guidelines to help ensure submissions align with the journal’s requirements. Accepted manuscripts will receive professional editorial review, formatting, and typesetting prior to publication.

Article Processing Charges (APC)

Synergy Publishers will waive all publication fees for accepted articles until December 31, 2026. During this period, every accepted article will be published Open Access at no costs to authors.

Open Access Policy

Synergy Publishers is committed to the principles of open access. All published articles are freely available under the Creative Commons Attribution (CC BY 4.0) license. This ensures that published research can be shared, reused, and built upon without restriction, thus, maximizing the visibility and impact of the published work. For more information, please refer to our Open Access Policy.

Peer Review

Synergy journals maintain a single-blind peer review process, where reviewers remain anonymous, but authors’ identities are disclosed. This approach ensures impartiality while safeguarding the integrity, clarity, and originality of accepted manuscripts. Further details are available in our Editorial Policy and Peer Review Policy.

Editorial Process

All submissions undergo a structured editorial workflow designed to guarantee fairness, transparency, and quality. Authors are encouraged to review the journal’s editorial process before submission to understand how manuscripts are screened, reviewed, and advanced to publication. Further details are available in our Editorial Policy.

 Plagiarism Screening

At Synergy, originality is non-negotiable. All submissions are screened using iThenticate via Crossref Similarity Check. While the software identifies potential overlaps, final evaluation is always conducted manually by the editorial team to distinguish acceptable similarity from unethical duplication. Authors may be asked to revise their manuscripts based on similarity reports before the review process proceeds.

Publication Ethics

Synergy upholds the highest standards of publishing integrity. Guided by the Committee on Publication Ethics (COPE) principles, we maintain a strict zero-tolerance policy on plagiarism, data fabrication, falsification, or unethical authorship practices. Editors are trained to enforce these standards consistently, ensuring that all published work is original, accurate, and ethically sound. For more details, please see our Publication Ethics Policy.

Digital Archive

Synergy is committed to the long-term preservation and accessibility of scholarly research. All Synergy journals are archived in Portico, which provides secure and permanent digital archiving for scholarly publications.

Advertising Policy

Synergy journals currently do not host or promote commercial advertising. This policy protects editorial independence and scientific neutrality.

Direct Marketing

Synergy promotes its journals through academic engagement rather than commercial advertising. Awareness campaigns include distributing journal information through the website, brochures, and targeted invitations to conference speakers, workshop presenters, and seminar participants whose work aligns with the journal’s scope.